© 2021 MJH Life Sciences™ and Patient Care Online. All rights reserved.
Pulmonology
Fixed-dose Albuterol/Budesonide Superior to Components for Asthma in Dual Phase 3 Trials
September 13, 2021
The albuterol/budesonide combination significantly reduced the risk of severe exacerbations and improved lung function in mild-to-moderate asthma.
Smoking, NSAID-exacerbated Respiratory Disease Among Risk Factors for Severe Asthma Identified in New Study
August 03, 2021
A new study found several risk factors associated with severe adult-onset asthma, including smoking, NSAID-exacerbated respiratory disease, and sibling count.
New Study Suggests COVID-19 Public Health Measures Linked to Decline in COPD Hospital Admissions
June 15, 2021
A new study found public health measures designed to curb COVID-19 transmissions may have fostered a significant side benefit: reduced COPD hospital admissions.